Metatron (MRNJ) Integrates Secure Chat App,
Marijuana/CBD App and Bitweed Bitcoin Payment Platform with
Sanguine Biotech (SGUI)
Dover, DE -- December 13, 2017 -- InvestorsHub NewsWire --
Metatron (OTC:
MRNJ), a technology pioneer specializing in the accelerated
release of over 2000 apps including Cannabis based, CBD, and
Vaporized secure chat apps via iTunes and Google Play, is pleased
to report the final stage development of Bitweed, a cryptocurrency
transaction and tracking app for Marijuana dispensaries and
consumers that we expect to evolve into its own token/coin.
Sanguine Biotech Corp (SGUI) now distributes the Metatron
developed and recent updated Cannaboids and Vaporized Secure Chat
app under its own iTunes account with Google Play soon to
follow.
The digital currency market's total value surpassed $500 billion
for the first time, smashing through this milestone amid signs of
growing interest in cryptocurrencies. The number of accounts on
Coinbase stood at 13.3 million at the end of November, a more than
100% increase from the 5.5 million that existed in
January, according to the New York Times.
"Bitcoin has risen over 1500% this
year, about 85% in the last few weeks, trading Bitcoin Futures and
Etherium up 15% yesterday ..this Blockchain revolution may make
look the internet and app booms seem like firecrackers. Cannabis is
legal in about 29 states, and Canada just made recreational
Marijuana legal, both multi-billion dollar Crypto and Cannabis
industries deserve safe and efficient payment solutions that
consumers should easily understand. Right now most people need
someone to show them how to set up a simple secure crypto walled.
We expect Bitweed and upcoming products to eventually evolve into
its own cryptocoin and solve this glaring market need" said CEO Joe
Riehl
Sanguine Corporation (SGUI) (through its subsidiary, SGN
LifeSciences), is engaged in discovering, developing and
commercializing novel biotechnologies. The company is focused on
the development and commercialization of perfluorocarbon based
therapeutic oxygen carriers. The Company's core product, PHER-02,
is a perfluorocarbon emulsion.
Our two companies plan to conduct a shared roll-out of mobile
applications geared to solve issues in the cannabis payment space
using Blockchain technology and Bitcoin options. These apps will be
marketed under Cannaboids (www.cannaboids.com), and Bitweed
brands while Sanguine provides necessary biotech and medical
research for Metatron (www.Metatroninc.com)app
development.
This announcement coincides with the launch of http://www.icocryptoblockchain.com, the premier
one-stop website soon to be app with the latest cryptocurrency
news, education, editorials, market capitalizations, trade volume
and ICO alerts.
"Bitcoin is a technological tour de force." [Source: FoxBusiness]
According to Forbes By 2020, the Cannabis industry is expected
to create more jobs than manufacturing. Overall legal marijuana
sales are set to increase from about 7 billion dollars in 2016 to
26.5 billion dollars 2020. Since Canada recently legalized
recreational marijuana nationwide, it will result in an additional
23 Billion dollar added to the industry over the same time period
according to Delotte.
Metatron an industry leader in the field of mobile app
development with over 2000 apps created, millions in sales and
downloads historically, has partnered with high profile companies
and clients worldwide and is poised to revolutionize the exploding
crypto and cannabis industries.
Through its app development division i-Mobilize, and as a
pioneer in emerging markets, Metatron was the first company to
release any Cannabis related apps on iTunes and has extensive
experience in processing payments through its Just Data Billing
division. Release date for the BitWeed app is expected first
quarter of next year.
Metatron is also pleased to announce a formal offer to
Buzzlink.com, a cannabis e-commerce platform for dispensaries and
other retailers. Buzzlink.com will be financed partially by the
issuance of preferred B series shares and we now accept Bitcoin,
soon other Coins, the first being Litecoin.
Metatron approved investors can acquire Series B shares in
blocks of various sizes. The first round investors will receive the
highest discount. Series B shares can be redeemed through the
Company, are immune to reverse splits, and will convert at 1 B
share to 50,000 common shares at a discount. There are a limited
number of B shares available and Metatron reserves the right to end
and change offering at any time.
Details available at:
http://metatroninc.com/series-b/
Metatron's Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?
id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
Crytpo consulting available now for existing shareholders and
App clients. Email ir@metatroninc.com for more
info.
Bitcoin Address: 1fYqUi5d8fanqQY5qWsp1NhV4Jj8UQxgv
Forward-Looking Statements:
Any statements made in this press release which are not
historical facts contain certain forward-looking statements, as
such term is defined in the Private Litigation Reform Act of 1995,
concerning potential developments affecting the business,
prospects, financial condition and other aspects of the company to
which this release pertains. These forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause our actual results of the specific items described
in this release, and the company's operations generally, to differ
materially from what is projected in such forward-looking
statements. Although such statements are based upon the best
judgments of management of the company as of the date of this
release, significant deviations in magnitude, timing and other
factors may result from business risks and uncertainties including,
without limitation, the company's need for additional financing,
which is not assured and which may result in dilution of
shareholders, the company's status as a small company with a
limited operating history, dependence on third parties and the
continuing popularity of the iOS/Android operating systems, general
market and economic conditions, technical factors, receipt of
revenues, and other factors, many of which are beyond the control
of the company. Although we believe that the expectations and
statements reflected in the forward-looking statements are
reasonable and accurate at time of release, we cannot guarantee
future results, levels of activity, performance, or achievements.
Moreover, neither we nor any other person assumes responsibility
for the accuracy and completeness of such statements, and we
disclaim any obligation or liability to update information
contained in any forward-looking statement or errors in press
releases. Metatron does not grow, sell or distribute any substances
that violate United States Law or the Controlled Substances
Act.
Metatron, Inc. 302-861-0431 ir@metatroninc.com SOURCE: Metatron,
Inc